SU.86.86（人胰腺導管癌細胞）
CBP60850
詢 價
索取STR
產品描述
產品數據庫
| I. General information | |
| Synonyms: | SU.86.86 |
| Background: | This cell line was developed from a wedge biopsy of a liver metastasis of a pancreatic ductal carcinoma. |
| Species: | Homo sapiens, human |
| Tissue: | pancreas; derived from metastatic site: liver |
| Disease: | ductal carcinoma |
| Gender: | Female, 57 years, Caucasian |
| Morphology: | epithelial |
| Growth Mode: | adherent |
| DNA Profile: | D5S818: 7,13 D13S317: 11,12 D7S820: 8,11 D16S539: 11,13 vWA: 17 THO1: 9.3 Amelogenin: X TPOX: 8 CSF1PO: 10,11 Our Cell Line Authentication Service |
| Culture Medium: |
RPMI-1640+10%FBS SU.86.86完全培養(yǎng)基，# CBP60850M |
| Cryopreservation medium: | 90%FBS+10%DMSO |
| Genes Expressed: | carcinoembryonic antigen (CEA) |
| Tumor Formation: | Yes, in nude mice inoculated subcutaneously with 10(7) cells. (The cells produce CEA, and grow in orthotopic and heterotopic positions in nude mice within 21 days at 100% frequency (5/5).) |
| Comments: | The cells can be lysed completely in vitro by autologous and allogeneic lymphokine activated killer (LAK) cells in the presence of interleukin 2 (IL-2). They are relatively insensitive to autologous and allogeneic natural killer (NK) cell lysis. The cells produce CEA, and grow in orthotopic and heterotopic positions in nude mice within 21 days at 100% frequency (5/5). For more information, please contact us (4008-750-250). |
